limit
data
exist
enter
spread
gener
popul
use
two
strategi
test
target
test
highrisk
individu
popul
screen
sequenc
individu
result
march
test
posit
target
test
popul
screen
approxim
iceland
popul
larg
fraction
posit
travel
outsid
iceland
fewer
year
old
posit
older
vs
target
test
vs
popul
screen
fewer
femal
posit
target
test
male
vs
came
eight
clade
seven
clade
one
b
clade
clade
composit
differ
test
group
chang
time
earli
target
test
clade
deriv
italian
austrian
ski
area
later
target
test
went
overtaken
common
clade
popul
screen
spread
wide
iceland
outsid
highrisk
group
sever
strain
caus
infect
rel
contribut
chang
rapidli
sever
acut
respiratori
syndrom
coronaviru
caus
cluster
sever
respiratori
ill
wuhan
china
late
character
pandem
great
econom
cost
mani
countri
adopt
unpreced
measur
curb
spread
viru
largescal
use
isol
quarantin
close
border
limit
public
gather
nationwid
lockdown
earli
report
case
seri
china
itali
indic
caus
vari
degre
ill
femal
children
underrepres
among
case
particular
among
sever
fatal
case
unclear
femal
children
less
like
infect
develop
first
infect
iceland
confirm
februari
march
individu
test
posit
iceland
island
inhabit
one
major
gateway
countri
intern
airport
million
passeng
per
year
show
enter
iceland
began
spread
within
countri
use
two
strategi
test
iceland
target
test
individu
high
risk
infect
popul
screen
accept
offer
free
test
genom
sequenc
reveal
close
relationship
corona
virus
mer
research
deposit
sequenc
gisaid
sequenc
genom
test
posit
establish
origin
viru
spread
popul
infect
individu
identifi
iceland
target
test
highrisk
individu
popul
screen
target
test
start
januari
focus
individu
high
risk
infect
symptomat
cough
fever
ach
short
breath
come
ski
area
austria
northern
itali
contact
contact
registr
test
onlin
sampl
collect
recent
travel
contact
posit
individu
symptom
compat
regist
sixday
period
iceland
test
newli
posit
place
isol
contact
posit
quarantin
week
symptomat
individu
quarantin
also
test
addit
isol
posit
quarantin
high
risk
infect
march
iceland
author
initi
ban
mass
gather
peopl
state
social
distanc
least
meter
maintain
march
ban
mass
gather
extend
peopl
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
test
recommend
take
nasopharyng
oropharyng
sampl
rna
sampl
isol
within
hour
individu
test
posit
contact
phone
team
design
author
track
infect
ask
symptom
start
recent
travel
previou
contact
infect
individu
also
ask
identifi
everyon
contact
hour
notic
first
symptom
long
interact
individu
intim
interact
regist
contact
contact
phone
request
go
week
quarantin
ask
symptom
symptom
develop
quarantin
test
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
run
use
chemag
viral
rna
kit
instrument
perkin
elmer
inputoutput
volum
respect
step
workflow
monitor
use
inhous
lim
virlab
barcod
greiner
tube
extract
sampl
test
perform
either
luh
decod
use
similar
quantit
realtim
pcr
qrtpcr
method
fast
viru
master
mix
assay
kit
control
kit
obtain
thermo
fisher
assay
mix
b
c
prepar
contain
dye
label
probe
specif
gene
sprotein
nprotein
respect
addit
assay
mix
contain
dye
label
probe
human
rnase
p
intern
control
sampl
rna
sampl
plate
dispens
three
well
plate
layout
addit
three
neg
templat
three
posit
control
assay
mix
ad
total
reaction
volum
per
sampl
sampl
aliquot
mix
decod
perform
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
valid
rna
extract
qrtpcr
method
decod
perform
use
sampl
previous
test
posit
neg
qrtpcr
assay
luh
neg
sampl
test
neg
decod
posit
test
luh
also
posit
decod
two
sampl
test
posit
luh
neg
decod
upon
subsequ
sequenc
see
viral
genom
could
detect
sampl
probabl
viral
particl
present
use
fisher
exact
test
test
differ
frequenc
posit
equal
year
age
compar
older
year
age
year
age
compar
equal
year
age
use
likelihood
ratio
test
base
logist
regress
calcul
p
valu
differ
frequenc
posit
sex
use
age
age
squar
covari
use
varianc
estim
base
binomi
distribut
calcul
confid
interv
fraction
posit
revers
transcript
rt
multiplex
pcr
perform
base
inform
provid
artic
network
initi
http
articnetwork
gener
cdna
short
extract
viral
rna
preincub
min
presenc
random
hexam
sampl
cool
ice
follow
rt
use
superscript
iv
thermofish
presenc
dtt
mm
rnaseout
inhibitor
thermo
fisher
min
follow
min
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
multiplex
pcr
result
cdna
perform
use
tile
scheme
primer
design
gener
overlap
amplicon
approxim
bp
tabl
primer
gener
provid
dr
david
stoddard
oxford
nanopor
technolog
two
pcr
reaction
done
sampl
use
primer
pool
b
respect
tabl
tabl
ligat
reaction
incub
min
ligat
sequenc
librari
purifi
hamilton
star
ng
liquid
handler
use
two
round
magnet
spri
bead
purif
volum
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
sequenc
librari
pool
samplespool
quantifi
use
qubit
dsdna
assay
thermo
fisher
sampl
dilut
appropri
denatur
final
load
concentr
pm
sampl
sequenc
illumina
miseq
sequenc
use
miseq
reagent
kit
illumina
pool
sequenc
use
dual
index
pairedend
sequenc
bp
cycl
data
acquisit
imag
run
time
approxim
hr
basecal
done
real
time
use
mc
fastq
file
gener
use
miseq
report
least
pf
read
base
qualiti
least
base
collect
run
amplicon
sequenc
align
refer
genom
use
bwa
mem
possibl
pcr
duplic
mark
markdupl
picard
tool
read
less
base
align
omit
align
result
align
filter
read
use
variant
call
bcftool
consensu
sequenc
gener
variant
report
homozyg
use
region
target
primer
allow
variant
allel
frequenc
one
individu
consensu
sequenc
mask
ambigu
nucleotid
n
posit
depth
coverag
strictli
less
read
restrict
base
qualiti
higher
consensu
sequenc
ambigu
nucleotid
discard
analysi
mutat
tabl
use
defin
haplogroupsclad
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
network
analysi
haplogroup
medianjoin
network
sequenc
gener
use
data
sequenc
effort
iceland
gisaid
avail
march
tabl
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
first
infect
individu
iceland
identifi
februari
return
northern
itali
design
highrisk
area
iceland
author
less
month
later
march
individu
test
posit
viru
target
test
particip
popul
screen
tabl
tabl
earli
target
test
posit
report
contact
known
infect
individu
compar
later
posit
popul
screen
recent
travel
outsid
iceland
substanti
neg
report
contact
infect
person
low
number
contact
certainli
known
contact
infect
person
quarantin
elig
popul
screen
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
figur
set
posit
older
narrow
age
distribut
tabl
specif
individu
age
test
posit
target
test
popul
screen
group
respect
substanti
lower
fraction
among
individu
year
age
target
test
popul
screen
respect
individu
year
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
age
test
target
test
popul
screen
combin
one
individu
posit
less
would
expect
fraction
posit
year
age
target
test
popul
screen
femal
test
male
respect
tabl
howev
fraction
male
test
posit
greater
fraction
femal
vs
target
test
posit
adjust
age
vs
popul
screen
adjust
age
figur
sequenc
rna
extract
posit
manag
cover
genom
sampl
sampl
call
sequenc
variant
found
gisaid
databas
figur
use
clade
inform
mutat
tabl
figur
show
sever
viru
lineag
clade
emerg
month
sinc
origin
outbreak
china
averag
mutat
separ
found
haplotyp
wuhan
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
haplotyp
earli
target
test
clade
haplotyp
figur
time
initi
popul
screen
travel
return
ski
resort
alp
request
selfquarantin
elig
particip
result
substanti
differ
composit
haplotyp
exampl
haplotyp
commonli
seen
travel
come
austria
earli
target
test
much
rarer
travel
popul
screen
complet
absent
travel
interestingli
haplotyp
common
popul
screen
target
test
total
haplotyp
popul
screen
compar
haplotyp
earli
target
test
one
common
haplotyp
travel
popul
screen
far
common
haplotyp
seen
travel
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
composit
haplotyp
chang
substanti
earli
target
test
later
target
test
figur
haplotyp
collect
made
haplotyp
earli
target
test
reduc
haplotyp
late
target
test
mostli
increas
frequenc
haplotyp
two
common
haplotyp
popul
screen
probabl
popul
screen
identifi
cluster
infect
individu
seed
area
design
highrisk
eg
uk
later
target
test
like
find
new
individu
cluster
target
test
extend
includ
highrisk
area
popul
screen
identifi
case
could
use
inform
contact
track
effort
haplotyp
analysi
base
sequenc
overlaid
contact
trace
network
show
good
concord
contact
identifi
trace
team
base
viral
sequenc
figur
pair
individu
found
contact
trace
consist
sequenc
data
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
individu
haplotyp
analysi
show
individu
infect
virus
haplotyp
commonli
import
northern
itali
austria
tabl
addit
two
individu
also
associ
cluster
howev
carri
distinct
strain
rest
cluster
potenti
acquir
travel
denmark
rare
mutat
g
identifi
cluster
outlin
figur
highli
inform
domest
spread
iceland
search
individu
carri
mutat
report
associ
cluster
result
two
individu
probabl
infect
someon
cluster
unknown
contact
test
posit
target
test
discov
popul
screen
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
inform
track
team
posit
individu
popul
screen
track
identifi
posit
individu
contact
exampl
top
two
individu
figur
test
posit
popul
screen
distinct
clade
travel
uk
contact
trace
three
later
test
posit
target
test
clade
overal
extens
genom
track
add
resolut
trace
transmiss
rout
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
paper
describ
enter
spread
iceland
popul
condit
iceland
favor
studi
kind
one
major
gateway
countri
singl
payer
healthcar
system
univers
access
infect
individu
identifi
target
test
individu
high
risk
infect
popul
screen
march
individu
particip
popul
screen
test
posit
viru
weak
design
screen
sampl
random
resid
iceland
invit
particip
concern
potenti
infect
like
particip
other
ask
peopl
symptom
particip
seek
help
healthcar
system
howev
close
half
particip
report
symptom
commonli
rhinorrhea
cough
healthcar
system
began
test
individu
consid
risk
infect
januari
test
first
infect
identifi
februari
march
test
posit
henc
high
risk
infect
eleven
time
like
test
posit
show
young
children
femal
less
like
test
posit
adult
male
respect
other
shown
children
femal
less
like
develop
sever
diseas
adult
male
respect
result
consist
suggest
children
femal
less
vulner
understand
spread
viru
determin
viru
mutat
spread
sequenc
viru
individu
test
posit
march
haplotyp
composit
virus
individu
identifi
popul
screen
differ
test
earli
target
test
haplotyp
fewer
haplotyp
henc
look
like
haplotyp
viru
propag
gener
popul
come
differ
sourc
perhap
brought
peopl
come
countri
yet
design
highrisk
area
furthermor
sequenc
divers
viru
popul
screen
greater
origin
target
screen
focus
peopl
come
home
ski
alp
henc
like
viru
carri
iceland
mani
countri
frequenc
infect
popul
screen
indic
viru
spread
extent
unless
increas
screen
effort
like
fail
effort
contain
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
distribut
haplotyp
depend
sampl
travel
statu
count
eight
haplotyp
seen
iceland
shown
depend
whether
posit
found
earli
target
test
popul
screen
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
figur
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
